[扩散性异常性肺神经内分泌细胞增生症 (DIPNECH) ]
P Le Guen1, N Poté2, M-P Debray3
1Service de pneumologie et centre de référence des maladies pulmonaires rares, hôpital Bichat, AP-HP Nord-Université Paris Cité, 46, rue Henri-Huchard, 75018 Paris, France.
Revue des maladies respiratoires
|March 28, 2025
概括
扩散性异常性肺神经内分泌细胞增生 (DIPNECH) 是一种罕见的肺部疾病. 慢性咳的早期诊断是关键,因为缺乏治疗指南,需要进一步的研究.
科学领域:
- 肺部病理学 肺部病理学
- 罕见疾病 罕见疾病
- 在瘤学瘤学.
背景情况:
- 扩散性异常性肺神经内分泌细胞增生 (DIPNECH) 是一种罕见的慢性疾病,主要影响绝经后妇女.
- 具有慢性咳,呼吸不全,支气管阻塞和特定CT发现的特征,通常通过组织学诊断.
- 组织学发现包括神经内分泌细胞增生,小瘤和潜在的癌状瘤或收缩性支气管炎.
研究的目的:
- 审查目前对DIPNECH的理解.
- 突出诊断挑战和潜在的治疗途径.
- 强调需要进一步的临床试验和标准化的后续方案.
主要方法:
- 对案例报告和回顾系列的文献综述.
- 对DIPNECH的临床,放射和组织学特征的分析.
- 探索潜在的治疗选择和监测策略.
主要成果:
- DIPNECH 潜伏地呈现出非特异性呼吸道症状.
- 诊断依赖于临床,成像和组织学证据的结合.
- 目前的文献缺乏确定的治疗建议.
结论:
- DIPNECH是一种罕见的疾病,具有瘤发展和慢性呼吸衰竭的潜在风险.
- 在中年女性呈现慢性咳的早期诊断至关重要.
- 实验性治疗,如mTOR抑制剂和体静止素类似物,需要临床验证;定期监测至关重要.
相关概念视频
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
Cellular Adaptation III: Hyperplasia
Hyperplasia is an increase in the number of cells in a tissue or organ due to enhanced cell division. It is an adaptive, controlled response to stimuli such as injury, hormones, or stress, involving mitosis to produce genetically identical cells and support tissue repair and regeneration.Tissue CapacityCertain tissues, including the epidermis, intestinal epithelium, bone marrow, and fibroblasts, have a high potential for hyperplasia. Others, such as bone, cartilage, and smooth muscle, show...
Cellular Adaptation IV: Dysplasia and Metaplasia
DysplasiaDysplasia refers to abnormal changes in the size, shape, and organization of mature cells, characterized by pleomorphism, nuclear abnormalities, and increased mitotic activity. It commonly affects epithelial tissues, including the cervix, gastrointestinal tract, respiratory mucosa, and endometrium. Although it may occur alongside hyperplasia, dysplasia is not a true adaptive response but a preneoplastic change with potential to progress to cancer.When confined above the basement...
Chronic Obstructive Pulmonary Disease I: Introduction
Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
Chronic Obstructive Pulmonary Disease II: Emphysema
Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...


